Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patients

Published:2012-08-16 Issue:5 Volume:43 Page:919-924
ISSN:1873-734X
Container-title:European Journal of Cardio-Thoracic Surgery
language:en
Short-container-title:

Author:

Poullis Michael,McShane James,Shaw Mathew,Shackcloth Michael,Page Richard,Mediratta Neeraj,Gosney John

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

http://academic.oup.com/ejcts/article-pdf/43/5/919/17765091/ezs464.pdf

Reference22 articles.

1. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas;Fujisawa;J Clin Oncol,1999

2. Prognosis of smokers following resection of pathological stage I non-small-cell lung carcinoma;Sawabata;Gen Thorac Cardiovasc Surg,2007

3. Myocardial stunning and dopamine receptor polymorphism;Poullis;Eur J Cardiothorac Surg,1999

4. Node-negative non-small-cell lung cancer: pathological staging and survival in 1765 consecutive cases;Robinson;J Thorac Oncol,2011

5. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications;Kosaka;Cancer Res,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Smoking Status an Issue in the Current Surgical Approach to Non-small Cell Lung Cancer?;World Journal of Surgery;2021-10-28

2. Long-term Outcomes After Lung Cancer Resection in Smokers: Analysis of the National Lung Screening Trial;World Journal of Surgery;2021-09-30

3. Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer;Annals of Surgical Oncology;2020-07-16

4. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand;Lung Cancer;2020-06

5. INTERVENTION OF RECOMBINANT HUMAN ENDOSTATIN COMBINED WITH IRESSA CAN REDUCE TOXIC SIDE EFFECTS AND IMPROVE SURVIVAL RATE IN PATIENTS WHO HAVE FAILED CHEMOTHERAPY FOR NON-SMALL CELL LUNG CANCER;ACTA MEDICA MEDITERR;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3